Gender Dependency of Circadian Blood Pressure and Heart Rate Profiles in Spontaneously Hypertensive Rats: Effects of Beta‐Blockers

References

• Ackermann H. BIAS. Biometrische Analyse von Stichproben. Epsilon Verlag, Hochheim, DarmstadtGermany 1997; 7
   Google Scholar
• Basset A., Laude D., Laurent S., Elghozi J. L. Contrasting circadian rhythms of blood pressure among inbred rat strains: recognition of dipper and non‐dipper patterns. J. Hypertens. 2004; 22: 727–737
   PubMed Web of Science ®Google Scholar
• Bode‐Boeger S. M., Boeger R. H., Kielstein J. T., Loeffler M., Schaffer J., Froelich J. C. Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosis. J. Investig. Med. 2000; 48: 125–132
   PubMedGoogle Scholar
• Broeders M. A., Doevendans P. A., Bekkers B. C., Bronsaer R., van Gorsel E., Heemskerk J. W., Egbrink M. G., van Breda E., Reneman R. S., van Der Zee R. Nebivolol, a third‐generation beta‐blocker that augments vascular nitric oxide release: endothelial beta(2)‐adrenergic receptor‐mediated nitric oxide production. Circulation 2000; 102: 677–684
   PubMed Web of Science ®Google Scholar
• Calhoun D. A., Zhu S. T., Chen Y. F., Oparil S. Gender and dietary NaCl in spontaneously hypertensive and Wistar‐Kyoto rats. Hypertension 1995; 26: 285–289
   PubMedGoogle Scholar
• Chandler M. P., DiCarlo S. E. Acute exercise and gender alter cardiac autonomic tonus differently in hypertensive and normotensive rats. Am. J. Physiol. 1998; 274: R510–R516
   PubMed Web of Science ®Google Scholar
• Cockcroft J. R., Chowienczyk P. J., Brett S. E., Chen C. P., Dupont A. G., Van Nueten L., Wooding S. J., Ritter J. M. Nebivolol vasodilates human forearm vasculature: evidence for an L‐arginine/NO‐dependent mechanism. J. Pharmacol. Exp. Ther. 1995; 274: 1067–1071
   PubMed Web of Science ®Google Scholar
• de Groot A. A., Mathy M. J., van Zwieten P. A., Peters S. L. Involvement of the beta3 adrenoceptor in nebivolol‐induced vasorelaxation in the rat aorta. J. Cardiovasc. Pharmacol. 2003; 42: 232–236
   PubMed Web of Science ®Google Scholar
• Forte P., Copland M., Smith L. M., Milne E., Sutherland J., Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349: 837–842
   PubMed Web of Science ®Google Scholar
• Forte P., Kneale B. J., Milne E., Chowienczyk P. J., Johnston A., Benjamin N., Ritter J. M. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 1998; 32: 730–734
   PubMed Web of Science ®Google Scholar
• Garban H. J., Buga G. M., Ignarro L. J. Estrogen receptor‐mediated vascular responsiveness to nebivolol: a novel endothelium‐related mechanism of therapeutic vasorelaxation. J. Cardiovasc. Pharmacol. 2004; 43: 638–644
   PubMedGoogle Scholar
• Georgescu A., Pluteanu F., Flonta M. L., Badila E., Dorobantu M., Popov D. The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery. Eur. J. Pharmacol. 2005; 508: 159–166
   PubMed Web of Science ®Google Scholar
• Gosgnach W., Boixel C., Nevo N., Poiraud T., Michel J. B. Nebivolol induces calcium‐independent signaling in endothelial cells by a possible beta‐adrenergic pathway. J. Cardiovasc. Pharmacol. 2001; 38: 191–199
   PubMedGoogle Scholar
• Hartig V., Lemmer B. Gender‐related circadian variations in blood pressure, plasma catecholamines and urinary excretion of nitric oxide and cGMP. Naunyn‐Schmiedbergs Arch. Pharmacol. 2003; 367: 438
   Google Scholar
• Janssen B. J., Oosting J., Tyssen C. M., Struyker‐Boudier H. A. Time‐dependent efficacy of antihypertensive agents in spontaneously hypertensive rats. Chronobiol. Int. 1993; 10: 420–434
   PubMed Web of Science ®Google Scholar
• Kaehoenen M., Tolvanen J. P., Sallinen K., Wu X., Poersti I. Influence of gender on control of arterial tone in experimental hypertension. Am. J. Physiol. 1998; 275: H15–H22
   Google Scholar
• Kakoki M., Hirata Y., Hayakawa H., Nishimatsu H., Suzuki Y., Nagata D., Suzuki E., Kikuchi K., Nagano T., Omata M. Effects of vasodilatory beta‐adrenoceptor antagonists on endothelium‐derived nitric oxide release in rat kidney. Hypertension 1999; 33: 467–471
   PubMed Web of Science ®Google Scholar
• Lemmer B. The importance of circadian rhythms in drug response in hypertension and coronary heart disease—from mice and men. Pharmacol. Ther. 2006, PMID 16480770
   PubMedGoogle Scholar
• Lemmer B., Bathe K., Lang P. H., Neumann G., Winkler H. Chronopharmacology of beta‐adrenoceptor‐blocking drugs: pharmacokinetic and pharmacodynamic studies in rats. J. Am. Coll. Toxicol. 1983; 2: 347–358
   Google Scholar
• Lemmer B., Winkler H., Ohm T., Fink M. Chronopharmacokinetics of beta‐receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 1985; 330: 42–49
   PubMedGoogle Scholar
• Lemmer B., Barmeier H., Schmidt S., Lang P. H. On the daily variation in the beta‐receptor‐adenylate cyclase‐cAMP‐phosphodiesterase system in rat forebrain. Chronobiol. Int. 1987; 4: 469–475
   PubMed Web of Science ®Google Scholar
• Lemmer B., Mattes A., Bohm M., Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 1993; 22: 97–101
   PubMed Web of Science ®Google Scholar
• Lomb N. R. Least‐squares frequency analysis of unequally spaced data. Astrophysics Space Sci. 1976; 39: 447–462
   Web of Science ®Google Scholar
• Luzier A. B., Killian A., Wilton J. H., Wilson M. F., Forrest A., Kazierad D. J. Gender‐related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin. Pharmacol. Ther. 1999; 66: 594–601
   PubMed Web of Science ®Google Scholar
• Maeda K., Ohkura S., Tsukamura H. Physiology of reproduction. The Handbook of Experimental Animals: The Laboratory Rat, G. J. Krinke. Academic Press, London 2000; 145–176
   Google Scholar
• Meier K., Gorbey S., Lemmer B. Effects of nebivolol and metoprolol on nitric oxide urinary excretion, on expression of eNOS and blood pressure in SH‐rats. Naunyn‐Schmiedbergs Arch. Pharmacol. 2004; 369(Suppl.1)R42
   Google Scholar
• Middeke M., Schrader J. Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. Br. Med. J. 1994; 308: 630–632
   PubMed Web of Science ®Google Scholar
• Millar‐Craig M. W., Mann S., Balasubramanian V., Altman D. G., Raftery E. B. Circadian rhythms in hypertension. Scott. Med. J. 1981; 26: 309–314
   PubMedGoogle Scholar
• Nuedling S., Kahlert S., Loebbert K., Doevendans P. A., Meyer R., Vetter H., Grohe C. 17 beta‐estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in‐vitro and in‐vivo. Cardiovasc. Res. 1999; 43: 666–674
   PubMed Web of Science ®Google Scholar
• Okamoto K., Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 1963; 27: 282–293
   PubMedGoogle Scholar
• Packer C. S., Pelaez N. J., Kramer J. A. Estrogen protects against hypertension in the spontaneously hypertensive rat, but its protective mechanism is unrelated to impaired arterial muscle relaxation. J. Gend. Specif. Med. 2001; 4: 20–27
   PubMedGoogle Scholar
• Panza J. A., Quyyumi A. A., Callahan T. S., Epstein S. E. Effect of antihypertensive treatment on endothelium‐dependent vascular relaxation in patients with essential hypertension. J. Am. Coll. Cardiol. 1993; 21: 1145–1151
   PubMed Web of Science ®Google Scholar
• Pauwels P. J., Gommeren W., Van Lommen G., Janssen P. A., Leysen J. E. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta‐adrenergic blockers. Mol. Pharmacol. 1988; 34: 843–851
   PubMed Web of Science ®Google Scholar
• Press W., Teukolsky S., Vetterling W., Flannery B. Numerical Recipes in Cambridge2nd ed. Cambridge University Press, Cambridge 1992
   Google Scholar
• Reckelhoff J. F., Zhang H., Srivastava K., Granger J. P. Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 1999; 34: 920–923
   PubMed Web of Science ®Google Scholar
• Ritter J. M. Nebivolol: endothelium‐mediated vasodilating effect. J. Cardiovasc. Pharmacol. 2001; 38(Suppl.3)S13–S16
   PubMedGoogle Scholar
• Scargle J. D. Studies in astronomical time series, II: statistical aspects of spectral analysis of unevenly spaced data. Astrophys. J. 1982; 263: 835–853
   Web of Science ®Google Scholar
• Schiffer S., Pummer S., Witte K., Lemmer B. Cardiovascular regulation in TGR(mREN2)27 rats: 24 h variation in plasma catecholamines, angiotensin peptides, and telemetric heart rate variability. Chronobiol. Int. 2001; 18: 461–474
   PubMed Web of Science ®Google Scholar
• Touitou Y., Portaluppi F., Smolensky M. H., Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 2004; 21: 161–170
   PubMed Web of Science ®Google Scholar
• Tzemos N., Lim P. O., MacDonald T. M. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double‐blind, crossover study. Circulation 2001; 104: 511–514
   PubMed Web of Science ®Google Scholar
• Van de Water A., Janssens W., Van Neuten J., Xhonneux R., De Cree J., Verhaegen H., Reneman R. S., Janssen P. A. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta1‐adrenergic antagonist. J. Cardiovasc. Pharmacol. 1988; 11: 552–563
   PubMed Web of Science ®Google Scholar
• Witte K., Lemmer B. Free‐running rhythms in blood pressure and heart rate in normotensive Sprague‐Dawley rats. J. Interdiscpl. Cycle Res. 1993; 24: 328–334
   Web of Science ®Google Scholar
• Witte K., Schnecko A., Buijs R. M., van der Vliet J., Scalbert E., Delagrange P., Guardiola‐Lemaitre B., Lemmer B. Effects of SCN lesions on circadian blood pressure rhythm in normotensive and transgenic hypertensive rats. Chronobiol. Int. 1988; 15: 135–145
   Google Scholar
• Zecchin H. G., Bezerra R. M., Carvalheira J. B., Carvalho‐Filho M. A., Metze K., Franchini K. G., Saad M. J. Insulin signalling pathways in aorta and muscle from two animal models of insulin resistance—the obese middle‐aged and the spontaneously hypertensive rats. Diabetologia 2003; 46: 479–491
   PubMed Web of Science ®Google Scholar
• Zuther P. Ein Computerprogramm (ABPM-Fit) zur wissenschaftlichen und praxisbezogenen Auswertung von humanen und tierexperimentellen Blutdruckprofilen. University of Heidelberg, Germany 2003, M.D. thesis
   Google Scholar
• Zuther P., Lemmer B. Chronos‐Fit. Version 1.05., 2004, Available at: www.ma.uni‐heidelberg.de/inst/phar/forschungLemmer.html
   Google Scholar
• Zuther P., Witte K., Lemmer B. ABPM‐FIT and CV‐SORT: an easy‐to‐use software package for detailed analysis of data from ambulatory blood pressure monitoring. Blood Press. Monit. 1996; 1: 347–354
   PubMedGoogle Scholar